Fresenius Medical Care (FMS) free cash flow
Fresenius Medical Care (FMS) generated free cash flow of €1.77B in fiscal 2025 (the year ended December 31, 2025). That is 4.7% higher than the €1.69B of fiscal 2024. Figures as of 18 Nov 2026, 11:34 UTC, from Yahoo Finance.
Key facts
- Free cash flow, fiscal 2025
- €1.77B
- Change on fiscal 2024
- +4.7%
- Highest on record
- €1.94Bfiscal 2023
- Lowest on record
- €1.44Bfiscal 2022
- Fiscal years on record
- 42022–2025
Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.
Fresenius Medical Care free cash flow, in more detail
Across the 4 fiscal years on record (2022–2025), the highest was €1.94B in fiscal 2023 and the lowest €1.44B in fiscal 2022.
Free cash flow by fiscal year
Fresenius Medical Care free cash flow, year by year
| Fiscal year | Free cash flow | Change | Year ended |
|---|---|---|---|
| 2025 | €1.77B | 4.7% up | |
| 2024 | €1.69B | 13.2% down | |
| 2023 | €1.94B | 34.7% up | |
| 2022 | €1.44B | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.
How to read it
It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.
Free cash flow at health care companies of similar size
| Company | Free cash flow | Fiscal year |
|---|---|---|
| Cooper Companies COO | $433.70M | 2025 |
| Fresenius Medical Care FMS | €1.77B | 2025 |
| Kymera Therapeutics KYMR | -$234.34M | 2025 |
| DaVita DVA | $1.31B | 2025 |
| Halozyme Therapeutics HALO | $356.82M | 2025 |
| Universal Health Services UHS | $824.55M | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Fresenius Medical Care, figure by figure
- Fresenius Medical Care market cap
- Fresenius Medical Care revenue
- Fresenius Medical Care earnings
- Fresenius Medical Care earnings per share (EPS)
- Fresenius Medical Care P/E ratio
- Fresenius Medical Care P/S ratio
- Fresenius Medical Care P/B ratio
- Fresenius Medical Care operating margin
- Fresenius Medical Care dividend
- Fresenius Medical Care shares outstanding
- Fresenius Medical Care total debt
- Fresenius Medical Care cash on hand
- Fresenius Medical Care total assets
- Fresenius Medical Care return on equity (ROE)
- Fresenius Medical Care return on invested capital (ROIC)
Fresenius Medical Care (FMS) overview: price, valuation and scorecardAll health care companies by market value
Fresenius Medical Care free cash flow: questions and answers
What is Fresenius Medical Care's free cash flow?
Fresenius Medical Care (FMS) generated free cash flow of €1.77B in fiscal 2025 (the year ended December 31, 2025). That is 4.7% higher than the €1.69B of fiscal 2024.
What are the highest and lowest free cash flow figures on record for Fresenius Medical Care?
Across the 4 fiscal years on record (2022–2025), the highest was €1.94B in fiscal 2023 and the lowest €1.44B in fiscal 2022.
How is Fresenius Medical Care's free cash flow calculated?
Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Fresenius Medical Care it is on record here for 4 fiscal years, 2022 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: free cash flow
All stocks guides →- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
- How a DCF valuation works, and why inputs swing it
A discounted cash flow (DCF) valuation estimates what a business is worth today by forecasting the cash it will produce and discounting each year's cash back at a required rate of return. Because most of the value lies far in the future, a one-point change in growth or discount rate can move the answer by a quarter.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Fresenius Medical Care (FMS) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/FMS/free-cash-flow
Underlying data: Yahoo Finance.